The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
89BIO INC | COM | 282559103 | 8,010,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 7,642,993 | 470,338 | SH | SOLE | 470,338 | 0 | 0 | ||
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 290,815 | 264,377 | SH | SOLE | 264,377 | 0 | 0 | ||
ADVERUM BIOTECHNOLOGIES INC | COM NEW | 00773U207 | 7,335,014 | 1,069,244 | SH | SOLE | 1,069,244 | 0 | 0 | ||
AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 37,599,519 | 871,974 | SH | SOLE | 871,974 | 0 | 0 | ||
ALLOGENE THERAPEUTICS INC | COM | 019770106 | 6,681,858 | 2,867,750 | SH | SOLE | 2,867,750 | 0 | 0 | ||
AN2 THERAPEUTICS INC | COM | 037326105 | 4,491,111 | 2,088,889 | SH | SOLE | 2,088,889 | 0 | 0 | ||
ANAPTYSBIO INC | COM | 032724106 | 54,269,710 | 2,165,591 | SH | SOLE | 2,165,591 | 0 | 0 | ||
APPLIED THERAPEUTICS INC | COM | 03828A101 | 10,676,250 | 2,286,135 | SH | SOLE | 2,286,135 | 0 | 0 | ||
ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | 81,703,141 | 8,785,284 | SH | SOLE | 8,785,284 | 0 | 0 | ||
ARVINAS INC | COM | 04335A105 | 7,595,511 | 285,331 | SH | SOLE | 285,331 | 0 | 0 | ||
AUTOLUS THERAPEUTICS PLC | SPON ADS | 05280R100 | 16,089,168 | 4,623,324 | SH | SOLE | 4,623,324 | 0 | 0 | ||
BRIDGEBIO PHARMA INC | COM | 10806X102 | 92,013,859 | 3,632,604 | SH | SOLE | 3,632,604 | 0 | 0 | ||
CEREVEL THERAPEUTICS HLDNG I | COM | 15678U128 | 16,069,770 | 393,000 | SH | SOLE | 393,000 | 0 | 0 | ||
CG ONCOLOGY INC | COM | 156944100 | 24,308,900 | 770,000 | SH | SOLE | 770,000 | 0 | 0 | ||
COGENT BIOSCIENCES INC | COM | 19240Q201 | 7,895,336 | 936,576 | SH | SOLE | 936,576 | 0 | 0 | ||
DESIGN THERAPEUTICS INC | COM | 25056L103 | 4,003,850 | 1,195,179 | SH | SOLE | 1,195,179 | 0 | 0 | ||
DISC MEDICINE INC | COM | 254604101 | 79,090,368 | 1,754,834 | SH | SOLE | 1,754,834 | 0 | 0 | ||
EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 67,196,517 | 3,731,067 | SH | SOLE | 3,731,067 | 0 | 0 | ||
ELEVATION ONCOLOGY INC | COM | 28623U101 | 7,988,163 | 2,958,579 | SH | SOLE | 2,958,579 | 0 | 0 | ||
ERASCA INC | COM | 29479A108 | 38,270,270 | 16,216,216 | SH | SOLE | 16,216,216 | 0 | 0 | ||
HILLEVAX INC | COM | 43157M102 | 153,522,717 | 10,617,062 | SH | SOLE | 10,617,062 | 0 | 0 | ||
IMMATICS N.V | SHS | N44445109 | 13,391,539 | 1,152,456 | SH | SOLE | 1,152,456 | 0 | 0 | ||
IMMUNOCORE HLDGS PLC | ADS | 45258D105 | 3,685,944 | 108,762 | SH | SOLE | 108,762 | 0 | 0 | ||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 43,443,073 | 3,687,867 | SH | SOLE | 3,687,867 | 0 | 0 | ||
KRYSTAL BIOTECH INC | COM | 501147102 | 181,520,794 | 988,460 | SH | SOLE | 988,460 | 0 | 0 | ||
MACROGENICS INC | COM | 556099109 | 12,795,590 | 3,010,727 | SH | SOLE | 3,010,727 | 0 | 0 | ||
MEREO BIOPHARMA GROUP PLC | SPON ADS | 589492107 | 15,844,936 | 4,401,371 | SH | SOLE | 4,401,371 | 0 | 0 | ||
MERUS N V | COM | N5749R100 | 22,076,327 | 373,100 | SH | SOLE | 373,100 | 0 | 0 | ||
METAGENOMI INC | COM | 59102M104 | 1,002,423 | 245,692 | SH | SOLE | 245,692 | 0 | 0 | ||
MIRUM PHARMACEUTICALS INC | COM | 604749101 | 222,077,452 | 6,495,392 | SH | SOLE | 6,495,392 | 0 | 0 | ||
NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | N62509109 | 234,879,575 | 12,226,943 | SH | SOLE | 12,226,943 | 0 | 0 | ||
NEWAMSTERDAM PHARMA COMPANY | *W EXP 11/22/202 | N62509117 | 4,362,904 | 500,333 | SH | SOLE | 500,333 | 0 | 0 | ||
ORIC PHARMACEUTICALS INC | COM | 68622P109 | 29,289,985 | 4,142,855 | SH | SOLE | 4,142,855 | 0 | 0 | ||
PEPGEN INC | COM | 713317105 | 23,984,496 | 1,502,788 | SH | SOLE | 1,502,788 | 0 | 0 | ||
PHATHOM PHARMACEUTICALS INC | COM | 71722W107 | 104,125,574 | 10,109,279 | SH | SOLE | 10,109,279 | 0 | 0 | ||
PUMA BIOTECHNOLOGY INC | COM | 74587V107 | 9,983,939 | 3,062,558 | SH | SOLE | 3,062,558 | 0 | 0 | ||
REVOLUTION MEDICINES INC | COM | 76155X100 | 38,711,229 | 997,455 | SH | SOLE | 997,455 | 0 | 0 | ||
RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | 97,365,742 | 2,371,304 | SH | SOLE | 2,371,304 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 33,613,282 | 1,561,230 | SH | SOLE | 1,561,230 | 0 | 0 | ||
SAVARA INC | COM | 805111101 | 32,874,262 | 8,157,385 | SH | SOLE | 8,157,385 | 0 | 0 | ||
SILENCE THERAPEUTICS PLC | ADS | 82686Q101 | 21,823,229 | 1,148,591 | SH | SOLE | 1,148,591 | 0 | 0 | ||
SOLENO THERAPEUTICS INC | COM | 834203309 | 35,727,214 | 875,667 | SH | SOLE | 875,667 | 0 | 0 | ||
TARSUS PHARMACEUTICALS INC | COM | 87650L103 | 43,148,984 | 1,587,527 | SH | SOLE | 1,587,527 | 0 | 0 | ||
TREVI THERAPEUTICS INC | COM | 89532M101 | 21,995,648 | 7,381,090 | SH | SOLE | 7,381,090 | 0 | 0 | ||
TYRA BIOSCIENCES INC | COM | 90240B106 | 13,307,198 | 832,220 | SH | SOLE | 832,220 | 0 | 0 | ||
ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 17,467,500 | 425,000 | SH | SOLE | 425,000 | 0 | 0 | ||
VAXCYTE INC | COM | 92243G108 | 78,485,472 | 1,039,405 | SH | SOLE | 1,039,405 | 0 | 0 | ||
VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 47,925,487 | 3,314,349 | SH | SOLE | 3,314,349 | 0 | 0 |